非洲疫苗试验的影响、挑战和未来预测。
Impact, challenges, and future projections of vaccine trials in Africa.
机构信息
Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia.
出版信息
Am J Trop Med Hyg. 2013 Mar;88(3):414-9. doi: 10.4269/ajtmh.12-0576.
Abstract
Immunization remains the most cost effective method for the control of infectious diseases. Therefore, there is a global effort to deploy new vaccines for disease control and eradication. These new vaccines must be tested in the settings in which they will be used. This necessity has required the conduct of many vaccine trials in Africa, where several infectious diseases with significant public health impact are prevalent. However, these areas have peculiarities and are just beginning to gain expertise in the conduct of such trials. The vaccine developers and sponsors of these trials may also not be conversant with some issues unique to the trial site. The understanding gap from both partners can result in challenges if not addressed during the planning phase of the trial. This review seeks to highlight the issues surrounding the conduct of clinical trials in resource-constrained settings and suggests some ways of circumventing them.
摘要
免疫接种仍然是控制传染病的最具成本效益的方法。因此，全球正在努力部署新的疫苗来控制和消灭疾病。这些新疫苗必须在将要使用的环境中进行测试。这一必要性要求在非洲进行许多疫苗试验，因为那里有几种具有重大公共卫生影响的传染病流行。然而，这些地区具有特殊性，刚刚开始在进行此类试验方面获得专业知识。这些试验的疫苗开发商和赞助商也可能不熟悉试验现场特有的一些问题。如果在试验规划阶段不解决这两个合作伙伴之间的理解差距，可能会导致挑战。本综述旨在强调在资源有限的环境中进行临床试验所面临的问题，并提出一些解决方法。
相似文献
1
Impact, challenges, and future projections of vaccine trials in Africa.非洲疫苗试验的影响、挑战和未来预测。
Am J Trop Med Hyg. 2013 Mar;88(3):414-9. doi: 10.4269/ajtmh.12-0576.
2
Challenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon.亚洲和非洲开展疫苗试验的挑战和影响：新兴市场的新技术，2012 年 10 月 16 日-18 日；世界疫苗大会，里昂。
Hum Vaccin Immunother. 2013 Apr;9(4):924-7. doi: 10.4161/hv.23405. Epub 2013 Jan 15.
3
Biological challenges to effective vaccines in the developing world.发展中世界有效疫苗面临的生物学挑战。
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). doi: 10.1098/rstb.2014.0138.
4
Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.更新当前和未来加速疾病控制、消除和根除努力的补充免疫活动运营成本的证据基础。
BMC Public Health. 2014 Jan 22;14:67. doi: 10.1186/1471-2458-14-67.
5
Experience and challenges from clinical trials with malaria vaccines in Africa.在非洲进行疟疾疫苗临床试验的经验和挑战。
Malar J. 2013 Mar 4;12:86. doi: 10.1186/1475-2875-12-86.
6
Vaccines and global health.疫苗与全球健康。
Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2733-42. doi: 10.1098/rstb.2011.0076.
7
Mapping time use in clinical trials for vaccines against emerging infectious diseases.绘制疫苗防治新发传染病临床试验中的时间利用图。
Clin Trials. 2021 Jun;18(3):286-294. doi: 10.1177/1740774520977283. Epub 2021 Mar 2.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.霍乱疫苗试验的设计与分析：来自孟加拉国的近期经验教训。
Int J Epidemiol. 1993 Aug;22(4):724-30. doi: 10.1093/ije/22.4.724.
10
Evaluating new vaccines for developing countries. Efficacy or effectiveness?评估面向发展中国家的新型疫苗。是效力还是效果？
JAMA. 1996 Feb 7;275(5):390-7.
引用本文的文献
1
Strategies to build trust in the conduct of clinical trials: Stakeholders' views in a qualitative study in Ghana.在临床试验开展过程中建立信任的策略：加纳一项定性研究中利益相关者的观点
PLOS Glob Public Health. 2025 Apr 8;5(4):e0003201. doi: 10.1371/journal.pgph.0003201. eCollection 2025.
2
Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.非洲疫苗临床试验的差距：COVID-19大流行之前、期间和之后的混合范围审查与文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2481802. doi: 10.1080/21645515.2025.2481802. Epub 2025 Mar 25.
3
Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.非洲 COVID-19 疫苗的有效性和效果：系统评价。
PLoS One. 2024 Jun 28;19(6):e0306309. doi: 10.1371/journal.pone.0306309. eCollection 2024.
4
Defining clinical trial quality from the perspective of resource-limited settings: A qualitative study based on interviews with investigators, sponsors, and monitors conducting clinical trials in sub-Saharan Africa.从资源有限环境的角度定义临床试验质量：一项基于对在撒哈拉以南非洲开展临床试验的研究者、申办者和监查员进行访谈的定性研究。
PLoS Negl Trop Dis. 2022 Jan 27;16(1):e0010121. doi: 10.1371/journal.pntd.0010121. eCollection 2022 Jan.
5
Conducting clinical research in a resource-constrained setting: lessons from a longitudinal cohort study in The Gambia.在资源有限的环境中开展临床研究：来自冈比亚纵向队列研究的经验教训。
BMJ Glob Health. 2021 Aug;6(8). doi: 10.1136/bmjgh-2021-006419.
6
A review of the safety of vaccines used in routine immunization in Africa.非洲常规免疫中使用的疫苗的安全性综述。
Afr Health Sci. 2020 Mar;20(1):227-237. doi: 10.4314/ahs.v20i1.28.
7
Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea.在冈比亚和巴布亚新几内亚开展的一项利用系统生物学识别新生儿疫苗免疫原性标志物的纵向队列研究的临床方案。
Front Pediatr. 2020 Apr 30;8:197. doi: 10.3389/fped.2020.00197. eCollection 2020.
8
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.一种基于系统记分卡的方法，用于在受影响国家为拉沙热疫苗临床试验做准备时进行现场评估。
Pilot Feasibility Stud. 2020 Feb 13;6:24. doi: 10.1186/s40814-020-00567-4. eCollection 2020.
9
Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.提高撒哈拉以南非洲地区临床试验方案的适用性：一项混合方法研究。
Glob Health Res Policy. 2017 Apr 7;2:11. doi: 10.1186/s41256-017-0031-1. eCollection 2017.
10
Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.临床试验资金的特点：横断面调查及拟议指南
BMJ Open. 2017 Oct 5;7(10):e015997. doi: 10.1136/bmjopen-2017-015997.
本文引用的文献
1
Human immune responses to vaccines in the first year of life: biological, socio-economic and ethical issues - a viewpoint.人类在生命第一年对疫苗的免疫反应：生物学、社会经济和伦理问题——观点。
Vaccine. 2013 May 17;31(21):2483-8. doi: 10.1016/j.vaccine.2012.06.018. Epub 2012 Jun 19.
2
Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.发展中国家流感嗜血杆菌 b 型结合疫苗的开发和技术转让。
Vaccine. 2012 Jul 13;30(33):4897-906. doi: 10.1016/j.vaccine.2012.05.058. Epub 2012 Jun 6.
3
Drug partnerships and global practices.药物合作与全球实践。
Health Place. 2012 May;18(3):481-9. doi: 10.1016/j.healthplace.2011.05.004.
4
Current status of phase I clinical trials in Asia: an academic perspectives.亚洲I期临床试验的现状：学术视角
Acta Med Indones. 2012 Jan;44(1):71-7.
5
Informed consent on trial.试验知情同意书。
Nature. 2012 Jan 30;482(7383):16. doi: 10.1038/482016a.
6
Adaptive trial design: could we use this approach to improve clinical trials in the field of global health?适应性试验设计：我们能否采用这种方法来改进全球卫生领域的临床试验？
Am J Trop Med Hyg. 2011 Dec;85(6):967-70. doi: 10.4269/ajtmh.2011.11-0151.
7
Pediatric clinical trials in Latin America and Guyana: present views of local practitioners and ways to embrace the future.拉丁美洲和圭亚那的儿科临床试验：当地从业者的现状观点和拥抱未来的方式。
Paediatr Drugs. 2011 Aug 1;13(4):257-65. doi: 10.2165/11590350-000000000-00000.
8
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.在非洲人中，脑膜炎球菌 A 结合疫苗的免疫原性和安全性。
N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812.
9
Blood sample volumes in child health research: review of safe limits.儿童健康研究中的血液样本量：安全限度综述。
Bull World Health Organ. 2011 Jan 1;89(1):46-53. doi: 10.2471/BLT.10.080010. Epub 2010 Sep 10.
10
Small(pox) success?（天花）成功了？
Cien Saude Colet. 2011 Feb;16(2):591-7. doi: 10.1590/s1413-81232011000200022.
Zotero 插件